Skip to main content
. 2002 Nov;236(5):667–675. doi: 10.1097/00000658-200211000-00018

graphic file with name 18FF3.jpg

Figure 3. Effect of methylprednisolone on anti-CD154 mAb in the C57BL/6 into BALB/c cardiac transplant model. The concomitant use of neither a short (day 0–3) nor a long (day 0–7) course of methylprednisolone affected graft survival prolongation induced by a single dose of anti-CD154 mAb. There was no statistical significance among the groups of sMR1 with or without methylprednisolone.